Since the company was founded, European markets have been of great strategic importance for hameln. Through many years of close cooperation with local distribution partners, we were able to introduce numerous products across different markets and firmly establish the "hameln" brand. Along with our partners, we have been able to establish and consolidate good market positions across the region, despite increased regulatory requirements and increasing competition in recent years. For historical reasons and due to its strategic importance, hameln products are distributed directly in Germany and in the United Kingdom and this sales model was also implemented in Austria in 2013. In order to expand our market presence, we are increasingly looking towards growing our presence in Eastern Europe
We look forward to hearing from you if you have any questions about our country presence and products.
Marina Stock Sales Director Western Europe
Tel.:+49 5151 581-515
Fax:49 5151 581-501
Jana-Linda Pettenpohl Sales & Marketing Europa
Tel.: +49 5151 581-360
Fax: +49 5151 581-501
We currently operate in the following European markets:
hameln pharma plus gmbh
Langes Feld 13
Managing Director: Christian Kanzelmeyer
Tel: +49 5151 581 576
Fax: +49 5151 581 501
hameln is a leading provider of high-quality generic injectable drugs that specialize in critical care. Our product portfolio includes an increasing number of products in various presentations including anesthetics, sedatives, analgesics and antidotes. Our products are used today in more than 40 countries worldwide. Doctors, pharmacists and nurses rely on our know-how and experience..